AU2003289990A1 - Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections - Google Patents

Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections

Info

Publication number
AU2003289990A1
AU2003289990A1 AU2003289990A AU2003289990A AU2003289990A1 AU 2003289990 A1 AU2003289990 A1 AU 2003289990A1 AU 2003289990 A AU2003289990 A AU 2003289990A AU 2003289990 A AU2003289990 A AU 2003289990A AU 2003289990 A1 AU2003289990 A1 AU 2003289990A1
Authority
AU
Australia
Prior art keywords
hiv
peptides
expression
viral infections
cytoplasmic domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003289990A
Inventor
Matthias Dittmar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Heidelberg
Original Assignee
Universitaet Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Heidelberg filed Critical Universitaet Heidelberg
Publication of AU2003289990A1 publication Critical patent/AU2003289990A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003289990A 2002-12-10 2003-12-09 Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections Abandoned AU2003289990A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10257770A DE10257770A1 (en) 2002-12-10 2002-12-10 Expression of peptides in the cytoplasmic region of HIV-gp41 to inhibit viral infections
DE10257770.6 2002-12-10
PCT/EP2003/013939 WO2004052924A1 (en) 2002-12-10 2003-12-09 Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections

Publications (1)

Publication Number Publication Date
AU2003289990A1 true AU2003289990A1 (en) 2004-06-30

Family

ID=32477538

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003289990A Abandoned AU2003289990A1 (en) 2002-12-10 2003-12-09 Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections

Country Status (3)

Country Link
AU (1) AU2003289990A1 (en)
DE (1) DE10257770A1 (en)
WO (1) WO2004052924A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007018550A2 (en) * 2004-09-08 2007-02-15 The United States Of America As Represented By The Secretary Of Health And Human Services, Nih Compositions and methods for the detection of hiv-1/hiv-2 infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08503704A (en) * 1992-11-23 1996-04-23 プレジデント アンド フェロウズ オブ ハーバード カレッジ GP41 variants and their use as HIV therapeutics
DE19957838C2 (en) * 1999-11-25 2002-11-21 Pette Heinrich Inst Gene therapy of HIV-infected people through expression of membrane-anchored gp41 peptides

Also Published As

Publication number Publication date
WO2004052924A1 (en) 2004-06-24
DE10257770A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU2003297547A1 (en) Tandem tetramerisation-polymerisation of olefins
AU2003238456A1 (en) Viral vector
AU2003221824A1 (en) Barge-mounted tidal-powered desalinization system
AU2003268165A1 (en) Transit system
AU2003299718A1 (en) Velocity enhancement for ofdm systems
AU2003256364A1 (en) Break away fastening system
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
AU2003235284A1 (en) Perfect airtight-type cage system for protecting transition of pathogen
AU2003238767A1 (en) Dot-elisa for the detection of animal viruses
AU2003217991A1 (en) Hardware implementation of the secure hash standard
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2003290563A1 (en) Leptin-related peptides
AU2003901876A0 (en) Viral vector
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
EP1572950A3 (en) Single domain tdf-related compounds and analogs thereof
AU2003206367A1 (en) Technical field of the invention
AU2003257637A1 (en) Proline derivatives
AU2003206510A1 (en) Gazeification de dechets par plasma
AU2003225394A1 (en) Necktie wearing-device
AU2002950473A0 (en) Expression system
AU2003205623A1 (en) Prion protein carrier-conjugates
AU2003289990A1 (en) Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections
AU2003280896A1 (en) Detection of demyelination
AU2003246091A1 (en) Mkk7 activation inhibitor
AU2003262638A1 (en) Biotinylation of proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase